IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma (Q34440364)
scientific article published on September 15, 1997
Language:
(P31) (Q13442814)
(P50) (Q1758880)
(P304) 2188-2195
(P407) (Q1860)
(P433) 6
(P478) 90
(P577) Monday, September 1, 1997
Monday, September 15, 1997
(P921) (Q79460)
(Q412323)
(Q422248)
(P953) http://www.bloodjournal.org/cgi/content/abstract/90/6/2188
(P1433) (Q885070)
(P1476) "IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma" (language: en)
(P2093) D. G. Maloney
A. J. Grillo-López
C. A. White
D. Bodkin
R. J. Schilder
J. A. Neidhart
N. Janakiraman
K. A. Foon
T. M. Liles
B. K. Dallaire
K. Wey
I. Royston
T. Davis
other details
description scientific article published on September 15, 1997

External Links